To produce a summary of the published evidence of the barriers and facilitators for hospital-based routine HIV testing in high-income countries.
Introduction
HIV infection is a major global public health threat and is responsible for significant morbidity and mortality [1] , despite recent progress in treatment and care [2] . Public Health England reports that 13% (13 500) of the 101 200 people who were estimated to be living with HIV in the UK in 2015 were unaware of their HIV infection [3] . Similarly, the Centres for Disease Control and Prevention (CDC) surveillance data show that 13% of the 1.2 million people living with HIV in the US in 2013 were undiagnosed [4] . Furthermore, 39% of those diagnosed with HIV in the UK in 2015 were diagnosed with CD4 cell counts < 350 cells/lL, [3] and 46% of people diagnosed with HIV infection in the US in 2015 were diagnosed with CD4 cell counts < 200 cells/lL [4] . Late-stage HIV diagnosis is associated with increased morbidity and mortality [5] , greater onward transmission [6, 7] and high cost of treatment and care [8] .
Historically HIV testing was targeted, based on clinical suspicion and risk assessment. There is now evidence to suggest that targeted strategies result in missed HIV cases, sometimes even when patients present with HIV-associated conditions [9] [10] [11] [12] [13] [14] . A recent randomized trial comparing universal testing with targeted testing in an emergency department (ED) in the US, showed that routine testing, defined as testing regardless of risk or clinical condition, identified more HIV cases than targeted testing [15] .
In recognition of the benefits of early HIV diagnosis, the CDC published its revised HIV testing guidelines in September 2006 recommending routine opt-out HIV screening for all people aged 13-64 years attending any healthcare setting, including the ED, in areas where the prevalence of diagnosed HIV infection in the population exceeds 0.1% [16] . The UK national HIV testing guidelines (released in 2008) recommended HIV screening in various healthcare settings including all medical admissions in patients aged 16-59 years in areas of HIV prevalence of more than two per 1000 population [17] [18] [19] . Despite the recommendations for routine offer of HIV testing, a systematic review showed that the HIV testing coverage in settings where routine testing is recommended was just 29.5% [20] .
In the present paper, we aimed to review the literature systematically to identify the facilitators and barriers to HIV screening in EDs in the US, and in acute medical units (AMUs) and EDs in the UK; other high-income countries were not included, because their guidelines do not recommend routine testing for HIV [21] [22] [23] . Acute medical units serve as extensions of EDs in many hospitals in the UK, where patients are transferred directly from EDs, pending full admission to wards or discharge. We focused on EDs and AMUs because they are attended by a large number of patients, a proportion of whom may not have access to other healthcare facilities, especially in the US. They are also the point of entry into health services for many. We hope to produce a summary of existing evidence that will help stakeholders and policy makers implement routine HIV testing and translate into practice what is already recommended.
Methods
This review was conducted and presented in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendation [24] (Appendix S1).
We searched for publications which report on at least one of the following primary outcomes:
(1) Coverage of HIV testing (proportion of people tested for HIV out of those eligible for testing, as per the guidelines) and/or HIV testing uptake (proportion of patients accepted the HIV test offer out of those offered a routine HIV test) in EDs/AMUs, or (2) Facilitators (factors helping in increasing the offer of HIV testing and/or uptake) and/or Barriers (factors hindering the offer of HIV testing and/or uptake) of HIV testing in EDs/AMUs.
Electronic databases (MEDLINE and EMBASE) were searched for studies reporting on routine HIV screening (defined as the offer of HIV testing regardless of clinical presentation or HIV risk) as per CDC or UK HIV testing guidelines. We searched for terms, which referred to "facilitators", "barriers", "coverage", "uptake", "routine HIV testing", "UK" and "US" (Appendix S2).
Only studies including adults aged ≥ 13 years (US) and ≥ 16 years (UK) as per UK and CDC guidelines, attending EDs in the US or AMUs/EDs in the UK were included. Studies exploring the attitudes of providers of routine HIV screening for the above populations were also included.
No restriction on study design was applied. Only articles published in English language and in peer-reviewed journals in the period from 2006 and 2008 for American and British studies (reflecting the years when relevant recommendations were introduced in each country) respectively, up to 2015 were included. Grey literature and studies reporting on targeted HIV tests based on clinical suspicion and/or risk assessment HIV testing were excluded. We also manually searched the bibliographies of relevant articles. If more than one article reported on the same study population, only the article that provided most completed data was included. Review articles were also excluded to avoid overlap.
The primary investigator (AE) conducted all searches, and reviewed all relevant abstracts and full-length articles and extracted data using a standardized form (Appendix S3). A second independent investigator (KS) verified all the steps. Disagreements were resolved by consensus.
The mixed methods appraisal tool (MMAT) [25] was used to look for sources of bias in the studies.
We did not perform a meta-analysis, as included studies were heterogeneous. Hence, narrative synthesis and summary of the evidence was carried out. We carried out a thematic analysis for facilitators and barriers to HIV testing. After thorough review of the selected studies, we deduced the themes and categorized the findings according to whether they represented factors that helped or hindered HIV testing.
Results

Study selection
The process of study selection for inclusion is described in Figure 1 . Fourteen papers, seven British and seven American, were included in the review (Table 1) .
Study characteristics
Seven UK-based studies were included [26] [27] [28] [29] [30] [31] [32] , of which six were quantitative studies [26, [28] [29] [30] [31] [32] and one was a qualitative study [27] . Three of the quantitative studies were pilots of 3-month duration [26, 31, 32] , whereas the other three studies reported on experience of implementing policies of routine HIV testing for the duration of 12 months [29] , 21 months [30] , and 30 months [28] . The qualitative study [27] examined staff views about HIV testing before and after the implementation of the HIV testing programme [26, 27] .
Seven American studies were also included in the review [33] [34] [35] [36] [37] [38] [39] . Most of them were quantitative [33] [34] [35] [36] [37] [38] and one was a mixed-methods study [39] . Three studies described implementation of policies, for HIV screening in EDs of 9-month [35] , 56-month [36] and 60-month [39] durations, and reported on HIV testing coverage, uptake, barriers and facilitators. A further three studies explored staff and patient views about HIV screening [33, 37, 38] and the seventh was a pilot study reporting on HIV testing uptake and coverage [34] .
Risk of bias within studies
A summary of risk of bias assessment in each quantitative study (12 in total; six British and six American) included in the review using MMAT is shown in Table S1 . All but two [26, 38] of the 12 reports did not compare patient characteristics between all patients eligible for HIV screening and those approached for testing. In the absence of such data, selection bias and targeting of high-risk groups of patients could not be ruled out. Patients approached for testing may be different from the overall population eligible for routine screening. Studies, which used surveys, focus group and in-depth interviews, selected participants via a convenience sample or nonsystematic approach for selection [26, 37, 38] . This may have resulted in selection bias and participants may not be representative of all patients attending EDs. Full-text articles assessed for eligibility (n = 141)
Full-text articles excluded (n = 127)
Outcome not of interest (e.g. targeted or opt-in testing) = 77
Inappropriate setting (e.g. primary care or community) = 49
Incomplete data (unable to get the full text) = 1
Studies included in qualitative/quantitative synthesis (n = 14) Fig. 1 The process of study selection for inclusion in the review based on PRISMA guidance [45] . Staff in E ED and A AMU 3 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a Rapid oral fluid Existing ED staff n/a n/a n/a n/a n/a The qualitative study [27] scored 100% on the MMAT score, whereas the mixed-methods study [39] scored 75%. In the latter study, there were no data about the representativeness of the sample in relation to the population, in the quantitative component. The qualitative component did not give consideration to the influence that the researchers may have had on study findings.
Results of individual studies
HIV testing uptake, coverage and linkage to care As shown in Table 1 , the HIV testing uptake ranged from 53% to 84%. In the UK, HIV test uptake in EDs (62-63%) [26, 28] , was lower than AMUs (70-84%), [26, 30, 32] . In the US, the uptake levels in EDs ranged from 53% to 75% [36, 37] . Despite high levels of uptake, the HIV testing coverage in the UK and US was 10-38% [26, [29] [30] [31] [32] and 19-26% [34, 35] , respectively. Among those diagnosed, 88-100% in the UK and 74% to 100% in the US were linked into care.
Barriers to HIV testing Stigma, and confidentiality and privacy concerns: In a study by Thorton et al. [27] , staff identified HIV as an "exceptional" condition and suggested that this was a barrier to the offer and uptake of HIV testing in settings other than sexual health and antenatal clinics. However, they also felt that HIV testing in medical settings would help in normalizing and reducing the stigma attached to HIV [27] . Staff also raised confidentiality and privacy concerns as an obstacle to offering HIV testing in their settings, particularly in EDs [27] . Lack of privacy was also reported as a hurdle to HIV test offer by 58% of ED staff and 44% of AMU staff [26] . In another study, 35% of patients and 38% of staff expressed similar concerns regarding confidentiality and privacy of HIV testing in a setting such as an ED [38] . Staff fears about offering HIV tests: Staff expressed concern that they did not have the specialist knowledge needed to offer an HIV test [27] . During semi-structured interviews with eight staff members working in an ED, Knapp et al. reported that participants identified lack of training as a factor that hindered offer of HIV testing [39] . Similarly another study found that 82% and 65% of staff members in EDs and AMUs, respectively, reported that they would require additional training prior to offering an HIV test [26] . Operational barriers: Several operational barriers such as lack of time, concerns over result handling and provision of follow-up were identified as obstacles to HIV testing on offer in both the UK and US [26, 27, 32, 33, 38] . In the UK, more than 50% of staff in an ED and 40% of AMU staff identified insufficient time as a hurdle to the offer of HIV testing [26] . Staff from both settings also reiterated this concern during focus groups [27] . In the same focus groups in the UK, staff raised concerns about giving an HIV positive result and referring HIV positive patients for care [27] .
In an American study, clinical staff in EDs were asked about the perceived barriers to HIV testing in their ED before and after implementing a 6-month routine HIV testing project in the ED [33] . In the study, more staff members identified time constraints (62% vs. 51% at baseline) and concerns regarding follow-up (59% vs. 50% at baseline) as obstacles for HIV testing on offer in EDs. Conversely, concerns about other resources being inadequate, decreased from 70% to 60% over the study period [33] . Another American study showed that 60% and 35% of staff identified lack of time and concerns about provision of follow-up, respectively, as two factors that impeded offer of HIV testing in EDs [34] .
Semi-structured interviews with staff identified other barriers to the sustainability of the offer of HIV testing such as: lack of senior leadership engagement; insufficient involvement of frontline staff in the planning process; and inadequate systems of monitoring of and feedback about the offer and uptake of HIV testing to staff on the frontline [39] .
The short average length of stay in AMUs was been identified as a hindering factor to HIV testing in three UK-based studies [26, 29, 30] .
Facilitators of HIV testing
Partnership between ED/AMU medical staff and local specialist units Eight studies reported partnership between the ED/AMU staff and local HIV [26] [27] [28] 30, 31] or infectious diseases units [32, 35, 39] . The ED/AMU staff offered the HIV tests and the specialist HIV teams prepared patient information sheets, trained medical teams on how to offer an HIV test, and handled results and referral for care. Three of these studies described prelaunch meetings attended by all relevant stakeholders to define testing pathways and model of delivery as beneficial [30] [31] [32] .
Operational facilitators
Operational factors that were recognized as facilitators for the offer of HIV testing included nonwritten consent, nontargeted testing, simple result systems and not using point-of-care tests (POCT). In all UK testing projects verbal consent documented in medical notes was sufficient [26] [27] [28] [29] [30] [31] [32] . In four studies, venous sampling was used (rather than POCT which would require immediate provision of results and post-test counselling, for example) [29] [30] [31] [32] . In three studies, results were handled via a 'no news is good news' policy and only patients with a positive test result or those requiring repeat testing for any reason were contacted [30] [31] [32] . Staff in AMUs recognized the importance of routine offers of testing to all patients in facilitating HIV testing (as opposed to targeted testing) [27] .
In the US, Lin et al. [35] reported that operational changes to their HIV testing pathway impacted on the offer of HIV testing. Initially, selected staff dedicated only to HIV testing carried out opt-in HIV testing with POCT in their ED. Training all existing ED staff to offer HIV testing, using the electronic health record to prompt HIV testing for eligible patients, and switching from POCT to venous sampling for laboratory testing resulted in increased testing levels from 17% to 26% [35] . Another study also identified lack of written consent and removing lengthy pre-test counselling requirements as a factor which favoured the offer of HIV testing [34] .
Commitment and enthusiasm of medical staff offering the HIV test
The high-level commitment and motivation of medical staff (especially nurses) offering HIV tests was identified in two UK-based studies as a facilitator of offering HIV testing [30, 31] . Moreover, Rayment et al. showed that involvement of nurses in HIV testing together with adding blood sampling-based HIV testing to oral fluid testing, resulted in an increase in HIV testing level from 11% to 29% [28] . An American study evaluating a 5-year sustainability of HIV rapid testing in EDs identified that success was dependent on the enthusiasm of two clinical champions in a given ED [39] .
Patient-specific factors
Uptake of HIV testing when offered was high in most of the studies reviewed. Four studies [26, 32, 34, 36] showed that uptake of HIV testing was higher in younger age groups. Male sex also was associated with increased uptake of testing in two studies which reported this [26, 36] . As shown in Table 1 , perception of low HIV risk among patients was reported in three studies as a reason for declining an offer of HIV testing [32, 37, 38] .
Discussion
Routine HIV testing has already been shown to be feasible, acceptable by both patients and staff, effective in identifying new HIV cases and cost-effective [37, [40] [41] [42] [43] .
Despite this, studies have shown that routine HIV testing in nonspecialist settings remains low [20, 44] .
We found that uptake among those offered was high, suggesting that the barriers lie more with providers rather than patients. Medical staff identified several operational barriers to offering HIV testing such as time constraints and the need for more training. They expressed concerns about giving positive results and worried about what follow-up patients would receive, despite the existence of referral pathways. A recent report from the UK showed how these barriers were successfully addressed in EDs using 'notional' consent where staff ordered an HIV test for all patients requiring a blood test. Patients could decline testing after they had read a comprehensive leaflet. This innovative approach had raised testing rates from 2.9% to 61% [45] . Furthermore, it had identified 40% of the newly diagnosed patients compared to 25% diagnosed in Sexual Health clinics [46] . 'Notional' consent may not be a fully informed consent; however, diagnosing new infections earlier might outweigh any loss in patients' autonomy. Our review also identified some patient-specific factors that correlated with refusal of HIV test offer such as female gender, old age and low risk perception. The higher rates of HIV test uptake among younger age groups and males might be explained, in part, by the high HIV risk perception due to multiple sexual partners among young people and same-sex relationships among men.
We identified factors which seem to promote the offer of HIV testing. Several studies reported that blood sampling was preferred over POCT, which compelled immediate provision of results. The rationale seems to be that waiting for the return of the blood sample result would give staff time to prepare for giving the result. Staff also emphasized securing organisational buy-in for the testing policy. Another important facilitating factor from both countries that helped increase the number of HIV tests offered was the involvement of nurses and their ownership of the HIV testing initiative.
The less than optimal coverage of HIV testing in EDs and AMUs is due to low offer of testing rather than low uptake. If medical teams were to engage better with the offer of HIV testing, it is likely that the reservations and anxieties currently experienced will be alleviated. In turn, this might result in even higher levels of HIV test uptake by patients. This is supported by the fact that the HIV test uptake levels in antenatal clinics in both the UK and US have been consistently over 90% in recent years after initial low offer and uptake levels in the first few years after policy implementation [3, 4] . Furthermore, normalizing HIV as a condition and embedding HIV testing within standard clinical care may overcome some of the operational barriers commonly reported by medical facilities providers. However, targeted HIV testing might still be needed to complement routine HIV testing strategies considering the low coverage of the latter.
As described above the integration of a nonrapid HIV test -which requires a verbal consent only (as for other investigations) -within the normal clinical duties for ED/ AMU staff may well reduce provider-related barriers to offering HIV tests. They would simply have to take another sample (for HIV) when taking blood for other tests. However, close cooperation with local HIV specialist teams is paramount for sustaining such initiatives. Local specialist HIV teams could provide ongoing training for general medical staff about HIV testing and the rational for testing guidelines, and help handle the results and linkage to care. Ongoing support from and collaboration with specialist teams would also help to alleviate fears about HIV result giving and therefore the offer of HIV testing in the first place. In the longer term, healthcare workers' fears should not be a barrier to offering more rapid HIV testing.
Limitations
Our review has some limitations to be considered. Methodological limitations of individual studies could result in misleading overall conclusions. Some of the included studies lacked data on important outcomes such as uptake and coverage of HIV testing and so our summaries on these outcomes are based on very few studies. Moreover, some of the UK studies were in two different clinical settings: AMUs and EDs. This may affect the validity of the thematic analysis because some of the facilitators and/or barriers were identified only in two or three studies. Furthermore, studies were a mixture of proof-of-concept studies and effective sustainable implementation initiatives. Finally, it is not possible to extrapolate the conclusions of this review to other international healthcare settings.
Recommendations and conclusions
Providers considering the introduction of routine HIV screening in medical settings, as per CDC and UK guidelines, would need to ensure adequate funding, training, retraining following staff changes, clinical support and clear referral pathways as well as prior engagement with stakeholders to encourage motivation to change practice. Models of delivery and specific roles should be identified in advance. For instance, decisions should be made about the target population and setting (ED or AMU), staff offering the test (doctors or nurses or both) and type of HIV test (POCT or standard serology). Also, the supportive role of local HIV teams should be clarified. Based on published papers, successful approaches included training of ED/AMU staff, creating patient and staff information leaflets, and taking a leading role in handling positive results and linkage to care. Furthermore, the senior leadership of organizations need to show commitment funding and support of the policy for routine HIV testing. Creation of a system for monitoring, audit and feedback to frontline staff would also be beneficial. Other important stakeholders to involve would be local public health officials. It is of concern that, despite the fact that American and British HIV testing guidelines have recommended routine testing since 2006 and 2008 respectively, the adherence to these recommendations has not been high. Our systematic review has identified areas which providers may target to improve this, which, if successfully implemented, could help to normalize HIV, dramatically increase knowledge of HIV status, promote HIV prevention and ultimately avert unnecessary morbidity.
